• Alisol A, Cholesterol, and Autophagy in VCI

  2026-09-09

  This Theranostics study identifies NAMPT as a central mediator of Alisol A neuroprotection in atherosclerosis-related vascular cognitive impairment. Using complementary behavioral, biochemical, imaging, lipidomic, and genetic approaches, the authors connect AMPK/NAMPT/SIRT1 signaling with cholesterol homeostasis, oxidative-stress control, and PINK1/PARKIN-dependent mitophagy.

• Imipenem Workflows for Antibacterial Research

  2026-09-08

  Build reproducible Imipenem workflows that connect susceptibility testing, PBP-centered mechanism studies, immune response modulation, and sepsis animal model design. The article emphasizes preparation, assay controls, resistance-aware interpretation, and practical troubleshooting rather than unsupported clinical extrapolation.

• Galectin-1–FIP200 Axis in Hepatic Steatosis

  2026-09-08

  The reference study identifies galectin-1 as an upstream suppressor of hepatic autophagy that promotes steatosis, dyslipidemia, and insulin resistance through direct interaction with FIP200. Its combination of mouse gain-of-function experiments, proteomic analysis, interaction mapping, and mutational validation establishes the Gal-1–FIP200 axis as a mechanistic link between metabolic stress and defective autophagic flux.

• N6-Methyl-dATP for DNA Fidelity and AML Research

  2026-09-07

  N6-Methyl-dATP enables controlled tests of polymerase selectivity, methylation-dependent nucleotide recognition, and replication-associated genomic stability. This workflow connects rigorous biochemical controls with AML-focused assay design while clearly separating established findings from exploratory applications.

• Dimethyloxalylglycine (DMOG) Workflow Guide

  2026-09-07

  Dimethyloxalylglycine (DMOG) is a cell-permeable competitive PHD inhibitor used to stabilize HIF-1α and model hypoxia-related signaling under normoxic conditions. It is appropriate for controlled cellular and animal research, including hypoxia and inflammation studies, but is not intended for diagnostic, therapeutic, or medical use.

• RNA Clean and Concentrator Kit for NAFLD RNA

  2026-09-05

  Translate PINK1/Park2 mitophagy findings into cleaner, more reproducible RNA workflows for NAFLD research. This practical guide shows how to use a membrane-based RNA cleanup workflow for in vitro transcription products, assay controls, and RNA quality troubleshooting without overstating what purification alone can prove.

• CTOP: μ-Opioid Receptor Antagonist for Pain Research

  2026-09-04

  CTOP is a selective μ-opioid receptor antagonist peptide for opioid receptor binding studies and neuropharmacology opioid research. Its competitive MOR blockade provides a practical pharmacological control for testing opioid-dependent signaling, while recent mouse data define a brain-to-spinal circuit associated with mechanical hypersensitivity and tolerance.

• Trichostatin A (TSA) Assay Guide

  2026-09-04

  A practical, scenario-based guide to using Trichostatin A (TSA) in cell viability, proliferation, and cytotoxicity workflows. It explains how SKU A8183 can improve interpretability through controlled solvent handling, mechanistic controls, and evidence-based optimization.

• Resiquimod (R-848) in Thermal Ablation Workflows

  2026-09-03

  Resiquimod (R-848) provides a practical TLR7/8-driven bridge between local tumor ablation and innate immune activation. This workflow guide explains stock preparation, hydrogel-compatible assay design, thermal controls, and troubleshooting for chemo-immunomodulation studies.

• GlycoRNA–RBP Surface Domains and TAT Entry

  2026-09-03

  The bioRxiv preprint reports that cell-surface RNA-binding proteins and glycoRNAs organize into RNA-sensitive nanoclusters that interact with the cell-penetrating peptide TAT. Its central advance is functional: removing extracellular RNA or reducing TAT RNA-binding activity impairs peptide internalization, expanding the working definition of the cell surface.

• CTOP for μ-Opioid Receptor Research

  2026-09-02

  CTOP is a selective μ-opioid receptor antagonist for separating MOR-dependent signaling from downstream pain-circuit effects. This guide shows how to use it in receptor binding studies, cellular assays, and mechanistic pain models focused on opioid-induced mechanical hypersensitivity and tolerance.

• Selective Autophagy Tunes IRF3 Stability in Antiviral Immuni

  2026-09-02

  Wu and colleagues show that CALCOCO2/NDP52-dependent selective autophagy removes IRF3 in a virus-load-dependent manner, while the deubiquitinase PSMD14/POH1 protects IRF3 from lysosomal turnover. This mechanism links ubiquitin editing to autophagic clearance and explains how antiviral interferon production is balanced against excessive immune activation.

• HIV-1, Glutamate, and DNA Damage in Brain Pericytes

  2026-09-01

  The reference study shows that HIV-1 infection and latency make primary brain vascular pericytes unusually vulnerable to glutamate- and cytokine-associated DNA damage. Its combination of a latent HIV-1 model, γH2AX measurements, inflammatory reactivation tests, and DNA repair perturbation connects viral persistence with pericyte loss and blood–brain barrier dysfunction.

• Sphingosine-1-phosphate: Applied Workflows

  2026-09-01

  Build reproducible S1P assays for receptor signaling, neuronal apoptosis, and endothelial behavior with fresh-solution handling and concentration-aware controls. The workflow separates S1PR1-associated vascular responses from the S1PR3-linked apoptotic mechanism reported after intracerebral hemorrhage.

• Tolazoline: From Receptor Blockade to Translation

  2026-08-31

  Tolazoline is more than a conventional α2-adrenergic receptor antagonist: it is a mechanistic probe for separating presynaptic control of airway cholinergic tone from direct smooth-muscle effects, while its weaker ATP-sensitive potassium channel activity creates a second axis for islet research. This article outlines a rigorous translational strategy for using the compound without overstating selectivity.

8129 records 1/542 page Next 12345 下5页 Last page